A new state-of-the-art Facility for Systasy Bioscience GmBH at Martinsreid, Munich

Systasy Bioscience is pleased to announce a major milestone in its growth journey: We move into a newly constructed, state-of-the-art laboratory facility located in Martinsried, one of Europe’s leading biotech hubs and home to the Innovation and Start-up Center for Biotechnology.

This significant development marks a new chapter for Systasy as the company scales its research, innovation, and operational capabilities. The expansion comes in response to the increasing demand for its proprietary platform, which enables highly specific molecular profiling and pathway-based drug screening.

The new laboratory is custom designed to support Systasy’s expanding scientific team and to accommodate more sophisticated instrumentation, larger assay volumes, and advanced automation. The layout fosters collaboration while ensuring the flexibility needed to adapt to diverse project requirements and strategic partnerships.

This move is more than just a change of address — it’s a reflection of our growth and the trust our partners have placed in our science,” said Dr. Sven Wichert, CEO of Systasy Bioscience. “Moving to a state-of-the-art, top-tier lab with expansive facilities is a crucial milestone for Systasy Bioscience, empowering us to scale our operations, enhance innovation, and lead the discovery of novel transformative therapies to improve patient outcomes.”

Systasy extends its sincere appreciation to Smart Lab Architects for their pivotal role in designing and overseeing the laboratory build.

As Systasy settles into this new space, the team looks forward to deepening collaborations, accelerating project timelines, and continuing its mission to translate pathway biology into meaningful therapeutic insights.

Stay connected with us as we continue to grow and innovate!